Anti-interleukin-21 antibody and liraglutide for the preservation of β-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled, phase 2 trial

Publication date: Available online 1 March 2021Source: The Lancet Diabetes & EndocrinologyAuthor(s): Matthias von Herrath, Stephen C Bain, Bruce Bode, Jesper Ole Clausen, Ken Coppieters, Leylya Gaysina, Janusz Gumprecht, Troels Krarup Hansen, Chantal Mathieu, Cristobal Morales, Ofri Mosenzon, Stine Segel, George Tsoukas, Thomas R Pieber, Bernhard Ludvik, Rudolf Prager, Bernhard Paulweber, Christoph F Ebenbichler, B Keymeulen, C De Block
Source: The Lancet Diabetes and Endocrinology - Category: Endocrinology Source Type: research